Indalo Therapeutics Appoints Healthcare Industry Veteran and Serial Entrepreneur Michael Heffernan as Board Chair December 17, 2019
CommonSpirit Health taps startup (Notable Health) to reduce administrative workload December 12, 2019
Results of Fully-human BCMA CAR-T for the Treatment of Relapsed/Refractory Multiple Myeloma Co-developed by Innovent and IASO BIO Presented at the 2019 ASH Annual Meeting December 10, 2019
Precision BioSciences Presents Updated Interim Clinical Data at the ASH Annual Meeting from Relapsed / Refractory NHL and B-ALL Patients Treated at Dose Levels 1 & 2 in the Ongoing Phase 1/2a Clinical Trial of PBCAR0191, a Novel CD19 Targeted Allogeneic CAR T Therapy Candidate December 9, 2019
Orchard Therapeutics Showcases Clinical Data at the 61st American Society of Hematology Annual Meeting December 8, 2019
Beam Therapeutics Presents Preclinical Data for Complementary Base Editing Approaches for Hemoglobinopathies at ASH 2019 December 8, 2019
Unum Therapeutics Announces New Data at the American Society of Hematology (ASH) Annual Meeting December 7, 2019
Innovent Announces First Patient Dosed in Phase I Clinical Trial of Anti-LAG-3 Monoclonal Antibody in China December 5, 2019